InvestorsHub Logo
Followers 276
Posts 32740
Boards Moderated 0
Alias Born 11/14/2013

Re: None

Friday, 01/26/2024 8:18:28 AM

Friday, January 26, 2024 8:18:28 AM

Post# of 705610
I respectfully appreciate all the work Dstock and others are doing to gain due diligence on vaccine manufacturing by some BP.

While I can’t draw any conclusions, I did make one small observation.

Regarding the Merck/Moderna melanoma vaccine project, mRNA-4157, it is Moderna that is building manufacturing for potential future approval, not Merck.

(In earlier posts I’ve already shared my critique of mRNA cancer vaccines being a convoluted strategy, wherein targets (between 0 to 34 peptides) are chosen by human technology, coded on to a strand of mRNA, injected into the body, hopefully engulfed by dendritic cells, then hopefully effectively expressed by dendritic cells. It’s an expensive process that unfortunately still allows for tumor escape and for unknown reasons, adds an otherwise unnecessary step into what otherwise should be a more natural broad spectrum process.)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News